Randomized crossover trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on pulmonary artery pressure and right heart function (Echo).
Low altitude baseline measurements will be performed in Zurich (460m asl) including Echocardiography, Right heart catheterization, (six-minute walk test) 6MWT, pulmonary function test, clinical assessment and blood gas Analysis. Randomly assigned to the order of testing, the participants will be tested under simulated altitude (FiO2: 15.1% with the "AMC Altitrainer") and shamed altitude with the same device. Several times within the exposure, the pulmonary artery pressure and the right heart function will be assessed by echo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
28
Inhalation of deoxygenated air through a altitude simulator ("Altitrainer"), for approx. 1 hour. given by a facemask.
Inhalation of unmodified air through an altitude simulator ("Altitrainer") for approximately 1 hour given by a facemask
Respiratory Clinic, University Hospital of Zurich
Zurich, Switzerland
Echocardiographic assessment under hypoxia (FiO2: 15.1)
Pulmonary artery pressure measured by echo (TTE)
Time frame: 2 hours
Echocardiographic assessment of the right heart under hypoxia (FiO2: 15.1)
Right heart functions measured by echo (TTE) (fac, d-shaping, kinetic etc.)
Time frame: 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.